Home
Life Sciences

Sector: Life Sciences

Three things to know about the US government’s new strategy for standards development

Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP

Unified Patent Court grants preliminary injunction to 10x Genomics

A preliminary injunction strikes a heavy blow against NanoString Technologies which already withdrew from Germany due to a previous 10x injunction and now must do so from 16 more European countries

Life Sciences correspondent

Thought leadership from industry experts

Latest updates

EPO Enlarged Board of Appeal confirms use of post-published data to support inventive step

Latest content

UPC’s early cases suggest Munich becoming the focal point of European patent litigation

Initial surge in filings drops off as court clocks only one additional action since the first day

20 June 2023

Five Federal Circuit rulings you can’t ignore from the first half of 2023

Chief IP officers must study new US precedent on enablement, IPR estoppel, design patent obviousness, third-party finance disclosure and attorney fee recovery

14 June 2023

UPC week one in six key takeaways

Here’s what IAM readers need to know about early developments at the Unified Patent Court

09 June 2023

Patent families sold for $83,000 average in latest AST IP3 sale

One patent seller seeking $1 billion didn’t find a buyer among the likes of AST members Cisco, Google and Microsoft, however, 36 deals were done which garnered $3.12 million

07 June 2023

First unitary patent assertion occurs on UPC day one, as 10x Genomics follows up on German success

After winning first ever biotech AASI, 10x Genomics files first ever UP lawsuit

06 June 2023

New frontiers of life sciences IP strategy are posing challenges for patent professionals

IAM's latest quarterly Special Report takes a deep dive into the trends reshaping the work of pharma and biotech patent practitioners

02 June 2023

Making your CFO an IP believer: insights from Know Labs CFO and SVP of IP

Ahead of speaking at IPBC Global later this month, Peter Conley shares his wisdom on understanding and communicating value effectively

31 May 2023

Winning patent strategies for biosimilars

Long Read: As all signs point towards a fresh surge of biosimilars litigation, experts from Goodwin Procter and Gemini Law analyse the previous tranche of disputes to tease out the strategies that can still be useful to rights holders

31 May 2023

Patent Term Adjustment in Brazil at the centre of major battle for IP owners

Almost 50 cases have arisen in which IP owners are asserting their rights to an extended timeframe, the outcomes of which will have major ramifications in Latin America’s largest economy

30 May 2023

Ravgen assertion campaign highlights problems with US patent reforms

The diagnostics innovator has bagged a further $100 million in damages, but the country’s patent system has put unnecessary hurdles in the way, argues representative John Desmarais.

25 May 2023

Unlock unlimited access to all IAM content